Eczacıbaşı-Baxter

Eczacıbaşı-Baxter is a prominent healthcare company based in Turkey, originally formed as a 50-50 joint venture between the Eczacıbaşı Group and Baxter International. The company specializes in the production and marketing of hospital products, including intravenous solutions, parenteral nutrition, anesthesia, and advanced surgery products. It is a major player in the renal care market, providing essential products and services for both hemodialysis and peritoneal dialysis. In 2023, Eczacıbaşı Group acquired Baxter's shares to become the sole owner, though the company continues to operate as a key supplier of life-critical medical products in the region. Its manufacturing facility in Istanbul is recognized for high-quality standards and serves both the Turkish market and various export destinations.